Keywords
coronavirus disease 2019, post-COVID‑19 syndrome, long COVID‑19 syndrome, cardiovascular system.
How to Cite
Svintsitskyi, I. (2021). Cardiovascular implications of coronavirus disease 2019: features of clinical course, diagnosis, treatment. The Practitioner, (2), 24-27. Retrieved from https://plr.com.ua/index.php/journal/article/view/628
Abstract
The article presents the current views on the features of the clinical course, diagnosis and treatment of cardiovascular implications of coronavirus disease 2019 (COVID‑19). It is noted that patients with cardiovascular diseases have a more severe course of COVID‑19 infection and higher mortality rates, but final and complete data on frequency and types of long-term cardiovascular complications after COVID‑19, clinical consequences and long-term risks, clear management algorithms for post- COVID‑19 syndrome are currently missing.
References
1. Alwaqfi N.R., Ibrahim K.S. COVID‑19: an update and cardiac involvement. J. Cardiothorac. Surg. 2020. Vol. 15, № 1. ID239. DOI: 10.1186/s13019-020-01299-5.
2. Becker R.C. Anticipating the long-term cardiovascular effects of COVID‑19. J. Thromb. Thrombolysis. 2020. Vol. 50, № 3. P. 512-524.
DOI: 10.1007/s11239-020-02266-6.
3. Becker R.C. Toward understanding the 2019 Coronavirus and its impact on the heart. J. Thromb. Thrombolysis. 2020. Vol. 50, № 1. P. 33-42.
DOI: 10.1007/s11239-020-02107-6.
4. Borkowski L., Fal A.M., Filipiak K.J. i wsp. Charakterystyka choroby COVID‑19, objawy oraz skutki zdrowotne. Rekomendacje i doświadczenia polskich klinicystów. Warszawa, 2021. 45 s.
5. Dasgupta A., Kalhan A., Kalra S. Long term complications and rehabilitation of COVID‑19 patients. J. Pak. Med. Assoc. 2020. Vol. 70, Suppl. 3, № 5. P. S131–S135. DOI: 10.5455/JPMA.32.
6. Filipiak K.J. P. COVID‑19 complications — new types of cardiovascular disease in 2021? A few comments on: COVID‑19, post–COVID syndrome and the LONG COVID syndrome. Folia Cardiol. 2021. Vol. 16, № 1. P. 71-73. DOI: 10.5603/FC.2021.0010.
7. Frattini S., Maccagni G., Italia L. et al. Coronavirus disease 2019 and cardiovascular implications. J. Cardiovasc. Med (Hagerstown). 2020. Vol. 21, № 10. P. 725-732. DOI: 10.2459/JCM.0000000000001068.
8. Guzik T.J., Mohiddin S.A., Dimarco A. et al. COVID‑19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020. Vol. 116, № 10. P. 1666-1687. DOI: 10.1093/cvr/cvaa106.
9. Kurz D. J, Eberli F.R. Cardiovascular aspects of COVID‑19. Swiss Med. Wkly. 2020. Vol. 150. ID w20417. DOI: 10.4414/smw.2020.20417.
10. Mitrani R.D., Dabas N., Goldberger J.J. COVID‑19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020. Vol. 17, № 11. P. 1984-1990. DOI: 10.1016/j.hrthm.2020.06.026.
11. Niedziela J., Nowowiejska–Wiewióra A. Następstwa kardiologiczne COVID‑19. Kompleksowa opieka nad chorym z zespołem Post–COVID‑19 (PC19) / pod red. J. Jaroszewicza, M. Gąsiora. Warszawa: i–Medica Sp., 2021. S. 37-42.
12. Pęksa J.W., Czarnecka D. Zakażenie SARS-CoV-2 a choroby układu sercowo-naczyniowego — wybrane zagadnienia. Medycyna po Dyplomie. 2020. T. 29, № 5. S. 37-42.
13. Puntmann V.O., Carerj M.L., Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID‑19). JAMA Cardiol. 2020. Vol. 5, № 11. P. 1265-1273. DOI: 10.1001/jamacardio.2020.3557.
14. Salamanna F., Veronesi F., Martini L. et al. Post–COVID‑19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front. Med. (Lausanne). 2021. Vol. 8. ID653516. DOI: 10.3389/fmed.2021.653516.
15. Umbrajkar S., Stankowski R.V., Rezkalla S., Kloner R.A. Cardiovascular health and disease in the context of COVID‑19. Cardiol. Res. 2021. Vol. 12, № 2. P. 67-79. DOI: 10.14740/cr1199.
16. Xiong T. Y, Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long–term implications. Eur. Heart J. 2020. Vol. 41, № 19. P. 1798-1800. DOI: 10.1093/eurheartj/ehaa231.
17. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID‑19 and the cardiovascular system. Nat. Rev. Cardiol. 2020. Vol. 17, № 5. P. 259-260.
DOI: 10.1038/s41569-020-0360-5.
2. Becker R.C. Anticipating the long-term cardiovascular effects of COVID‑19. J. Thromb. Thrombolysis. 2020. Vol. 50, № 3. P. 512-524.
DOI: 10.1007/s11239-020-02266-6.
3. Becker R.C. Toward understanding the 2019 Coronavirus and its impact on the heart. J. Thromb. Thrombolysis. 2020. Vol. 50, № 1. P. 33-42.
DOI: 10.1007/s11239-020-02107-6.
4. Borkowski L., Fal A.M., Filipiak K.J. i wsp. Charakterystyka choroby COVID‑19, objawy oraz skutki zdrowotne. Rekomendacje i doświadczenia polskich klinicystów. Warszawa, 2021. 45 s.
5. Dasgupta A., Kalhan A., Kalra S. Long term complications and rehabilitation of COVID‑19 patients. J. Pak. Med. Assoc. 2020. Vol. 70, Suppl. 3, № 5. P. S131–S135. DOI: 10.5455/JPMA.32.
6. Filipiak K.J. P. COVID‑19 complications — new types of cardiovascular disease in 2021? A few comments on: COVID‑19, post–COVID syndrome and the LONG COVID syndrome. Folia Cardiol. 2021. Vol. 16, № 1. P. 71-73. DOI: 10.5603/FC.2021.0010.
7. Frattini S., Maccagni G., Italia L. et al. Coronavirus disease 2019 and cardiovascular implications. J. Cardiovasc. Med (Hagerstown). 2020. Vol. 21, № 10. P. 725-732. DOI: 10.2459/JCM.0000000000001068.
8. Guzik T.J., Mohiddin S.A., Dimarco A. et al. COVID‑19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020. Vol. 116, № 10. P. 1666-1687. DOI: 10.1093/cvr/cvaa106.
9. Kurz D. J, Eberli F.R. Cardiovascular aspects of COVID‑19. Swiss Med. Wkly. 2020. Vol. 150. ID w20417. DOI: 10.4414/smw.2020.20417.
10. Mitrani R.D., Dabas N., Goldberger J.J. COVID‑19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020. Vol. 17, № 11. P. 1984-1990. DOI: 10.1016/j.hrthm.2020.06.026.
11. Niedziela J., Nowowiejska–Wiewióra A. Następstwa kardiologiczne COVID‑19. Kompleksowa opieka nad chorym z zespołem Post–COVID‑19 (PC19) / pod red. J. Jaroszewicza, M. Gąsiora. Warszawa: i–Medica Sp., 2021. S. 37-42.
12. Pęksa J.W., Czarnecka D. Zakażenie SARS-CoV-2 a choroby układu sercowo-naczyniowego — wybrane zagadnienia. Medycyna po Dyplomie. 2020. T. 29, № 5. S. 37-42.
13. Puntmann V.O., Carerj M.L., Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID‑19). JAMA Cardiol. 2020. Vol. 5, № 11. P. 1265-1273. DOI: 10.1001/jamacardio.2020.3557.
14. Salamanna F., Veronesi F., Martini L. et al. Post–COVID‑19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front. Med. (Lausanne). 2021. Vol. 8. ID653516. DOI: 10.3389/fmed.2021.653516.
15. Umbrajkar S., Stankowski R.V., Rezkalla S., Kloner R.A. Cardiovascular health and disease in the context of COVID‑19. Cardiol. Res. 2021. Vol. 12, № 2. P. 67-79. DOI: 10.14740/cr1199.
16. Xiong T. Y, Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long–term implications. Eur. Heart J. 2020. Vol. 41, № 19. P. 1798-1800. DOI: 10.1093/eurheartj/ehaa231.
17. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID‑19 and the cardiovascular system. Nat. Rev. Cardiol. 2020. Vol. 17, № 5. P. 259-260.
DOI: 10.1038/s41569-020-0360-5.
Downloads
Download data is not yet available.